CSCI — COSCIENS Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for COSCIENS Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	24.3	65.3	50.6	6.68	16.4
Net Total Accounts Receivable
Net Total Receivables	2.28	3.67	2.16	0.29	2.47
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	27.6	70.8	55.5	11.3	24
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.179	0.192	0.216	11.6	11
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	37	80.1	56	23.7	35.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.74	7.77	7.04	1.31	7.22
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	23.8	27.1	20.3	2.71	21.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13.2	53	35.8	21	13.2
Total Liabilities & Shareholders' Equity	37	80.1	56	23.7	35.1
Total Common Shares Outstanding